GMED - NuVasive/Globus deal spread narrows amid report on optimism for regulatory approval
2023-08-18 16:47:19 ET
More on NuVasive
- NuVasive, Inc. ( NUVA ) Q2 2023 Earnings Call Transcript
- NuVasive: Critical Factors Unchanged, Reiterate Hold
- NuVasive Non-GAAP EPS of $0.56 beats by $0.01, revenue of $317.8M misses by $5.32M
- Globus Medical rises as Canaccord upgrades despite M&A uncertainty
- Nuvasive/Globus Medical deal spread widens amid report FTC considering lawsuit
- Globus Medical: Slightly Too Pricey Right Now
For further details see:
NuVasive/Globus deal spread narrows amid report on optimism for regulatory approval